Axcan Pharma Inc.
TSX : AXP
NASDAQ : AXCA

Axcan Pharma Inc.

November 19, 2007 15:00 ET

Axcan Announces Conference Call and Webcast for Fourth Quarter and Fiscal 2007 Results

MONT-SAINT-HILAIRE, QUEBEC--(Marketwire - Nov. 19, 2007) - Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that it will report financial results for the fourth quarter and fiscal year ended September 30, 2007, on Thursday, November 29, 2007, after market close.

Axcan will host a conference call at 8:30 A.M. ET, on Friday, November 30, 2007. Interested parties may also access the conference call by webcast at www.axcan.com. The webcast will be archived for 90 days.

The telephone numbers to access the conference call are (800) 733 7560 (Canada and United States) or (416) 644 3415 (international). Participants are kindly requested to connect ten minutes before the start of the conference call. A replay of the call will be available until December 7, 2007. The telephone numbers to access the replay of the call are (877) 289-8525 or (416) 640-1917, passcode 21249634#.

About Axcan Pharma

Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Contact Information

  • Axcan Pharma Inc.
    Isabelle Adjahi
    Senior Director, Investor Relations and Communications
    450-467-2600 ext. 2000
    www.axcan.com